MoneyWorks4Me

Smruthi Organics - Quaterly Results

04 Feb 2025 Evaluate
The sales surged to Rs. 312.50 millions, up 33.09% for the December 2024 quarter as against Rs. 234.81 millions during the corresponding quarter previous year.The Total Profit for the quarter ended December 2024 of Rs. 14.82 millions grew from Rs.-22.92 millions Operating profit Margin for the quarter ended December 2024 improved to 41.68% as compared to -11.77% of corresponding quarter ended December 2023


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202412 202312 % Var 202412 202312 % Var 202403 202303 % Var
Sales 312.50 234.81 33.09 879.14 879.85 -0.08 1276.43 1410.41 -9.50
Other Income 0.04 0.02 100.00 0.13 0.15 -13.33 0.76 1.07 -28.97
PBIDT 41.68 -11.77 -454.12 75.18 78.86 -4.67 120.31 98.87 21.69
Interest 5.08 3.19 59.25 13.54 10.36 30.69 14.08 8.22 71.29
PBDT 36.60 -14.96 -344.65 61.64 68.50 -10.01 106.23 90.65 17.19
Depreciation 13.70 14.52 -5.65 39.97 40.66 -1.70 56.53 45.72 23.64
PBT 22.90 -29.48 -177.68 21.67 27.84 -22.16 49.70 44.93 10.62
TAX 8.08 -6.56 -223.17 8.32 7.12 16.85 13.79 3.63 279.89
Deferred Tax 0.40 -0.23 -273.91 -0.52 -2.26 -76.99 -2.27 -10.97 -79.31
PAT 14.82 -22.92 -164.66 13.35 20.72 -35.57 35.91 41.30 -13.05
Equity 114.46 114.46 0.00 114.46 114.46 0.00 114.46 114.46 0.00
PBIDTM(%) 13.34 -5.01 -366.08 8.55 8.96 -4.59 9.43 7.01 34.46
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..